OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24
Zongqiang Hu, Yingpeng Zhao, Yuanyi Mang, et al.
Life Sciences (2023) Vol. 325, pp. 121773-121773
Open Access | Times Cited: 14
Zongqiang Hu, Yingpeng Zhao, Yuanyi Mang, et al.
Life Sciences (2023) Vol. 325, pp. 121773-121773
Open Access | Times Cited: 14
Showing 14 citing articles:
CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress
Yuanjun Lu, Yau-Tuen Chan, Junyu Wu, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101015-101015
Open Access | Times Cited: 21
Yuanjun Lu, Yau-Tuen Chan, Junyu Wu, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101015-101015
Open Access | Times Cited: 21
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond
Hui Shen, Xinyi Qi, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 17, pp. 6726-6767
Open Access | Times Cited: 7
Hui Shen, Xinyi Qi, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 17, pp. 6726-6767
Open Access | Times Cited: 7
Role of the USP family in autophagy regulation and cancer progression
Congcong Liu, Yuan Yuan, Yuxin Zhan, et al.
APOPTOSIS (2025)
Closed Access
Congcong Liu, Yuan Yuan, Yuxin Zhan, et al.
APOPTOSIS (2025)
Closed Access
SIRT3/6/7: promising therapeutic targets for pulmonary fibrosis
Pingping Huang, Qin Du, Qin Yan-ling, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Pingping Huang, Qin Du, Qin Yan-ling, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 4
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 4
The dark side of SIRT7
Francisco Alejandro Lagunas‐Rangel
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 11, pp. 2843-2861
Closed Access | Times Cited: 7
Francisco Alejandro Lagunas‐Rangel
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 11, pp. 2843-2861
Closed Access | Times Cited: 7
Related cellular signaling and consequent pathophysiological outcomes of ubiquitin specific protease 24
Song Xiaoyang, Boyu Xia, Xinrong Gao, et al.
Life Sciences (2024) Vol. 342, pp. 122512-122512
Closed Access | Times Cited: 2
Song Xiaoyang, Boyu Xia, Xinrong Gao, et al.
Life Sciences (2024) Vol. 342, pp. 122512-122512
Closed Access | Times Cited: 2
Gfi-1 modulates HMGB1-Mediated autophagy to overcome oxaliplatin resistance in colorectal cancer
Weijun Liu, Zhenyong Zhang, Liju Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29859-e29859
Open Access | Times Cited: 2
Weijun Liu, Zhenyong Zhang, Liju Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29859-e29859
Open Access | Times Cited: 2
USP24 promotes autophagy-dependent ferroptosis in hepatocellular carcinoma by reducing the K48-linked ubiquitination of Beclin1
Jiahui Cao, Shitao Wu, Senfeng Zhao, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Jiahui Cao, Shitao Wu, Senfeng Zhao, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Mechanisms of sorafenib resistance in hepatocellular carcinoma
Yuanjing Liang
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 8, pp. 102434-102434
Closed Access | Times Cited: 1
Yuanjing Liang
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 8, pp. 102434-102434
Closed Access | Times Cited: 1
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Critical role of miR-21/exosomal miR-21 in autophagy pathway
Mohamed J. Saadh, Morug Salih Mahdi, Omer Qutaiba B. Allela, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155275-155275
Closed Access
Mohamed J. Saadh, Morug Salih Mahdi, Omer Qutaiba B. Allela, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155275-155275
Closed Access
A combined model of six serum microRNAs as diagnostic markers for hepatocellular carcinoma
Bingqiang Zhang, Boyang Zhu, Junmei Yu, et al.
Clinica Chimica Acta (2024), pp. 119977-119977
Closed Access
Bingqiang Zhang, Boyang Zhu, Junmei Yu, et al.
Clinica Chimica Acta (2024), pp. 119977-119977
Closed Access
